Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian Krop

Showing results (1-10 of 69) with videos related to

Pageof 7
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2012
Doubling down on human epidermal growth factor receptor 2Ian Krop
Oncology (Williston Park, N.Y.)|March 8, 2012
Improving therapy for HER2-positive cancers through neoadjuvant studiesIan Krop
Clinical Advances in Hematology & Oncology : H&O|April 16, 2009
Managing trastuzumab-resistant breast cancerIan Krop
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 19, 2013
Trastuzumab emtansine: a novel antibody-drug conjugate for HER2-positive breast cancerIan Krop, Eric P Winer
The Lancet. Oncology|January 10, 2012
Further progress in HER2-directed therapyIan Krop, Eric P Winer
Journal of Oncology Practice|July 12, 2017
Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Focused Update Guideline SummaryIan Krop, Nofisat Ismaila, Vered Stearns
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 12, 2017
Reply to J.L. Blum et al and S. Lange et alIan Krop, Nofisat Ismaila, William Barlow, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 15, 2013
Pertuzumab: optimizing HER2 blockadeOtto Metzger-Filho, Eric P Winer, Ian Krop
Oncogene|February 19, 2002
Novel estrogen and tamoxifen induced genes identified by SAGE (Serial Analysis of Gene Expression)Pankaj Seth, Ian Krop, Dale Porter, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2013
Beyond trastuzumab and lapatinib: new options for HER2-positive breast cancer Dimitrios Zardavas, David Cameron, Ian Krop, et al.
Pageof 7

Showing results (1-10 of 69) with videos related to

Sort By:
Pageof 7
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2012
Doubling down on human epidermal growth factor receptor 2Ian Krop
Oncology (Williston Park, N.Y.)|March 8, 2012
Improving therapy for HER2-positive cancers through neoadjuvant studiesIan Krop
Clinical Advances in Hematology & Oncology : H&O|April 16, 2009
Managing trastuzumab-resistant breast cancerIan Krop
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 19, 2013
Trastuzumab emtansine: a novel antibody-drug conjugate for HER2-positive breast cancerIan Krop, Eric P Winer
The Lancet. Oncology|January 10, 2012
Further progress in HER2-directed therapyIan Krop, Eric P Winer
Journal of Oncology Practice|July 12, 2017
Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Focused Update Guideline SummaryIan Krop, Nofisat Ismaila, Vered Stearns
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 12, 2017
Reply to J.L. Blum et al and S. Lange et alIan Krop, Nofisat Ismaila, William Barlow, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 15, 2013
Pertuzumab: optimizing HER2 blockadeOtto Metzger-Filho, Eric P Winer, Ian Krop
Oncogene|February 19, 2002
Novel estrogen and tamoxifen induced genes identified by SAGE (Serial Analysis of Gene Expression)Pankaj Seth, Ian Krop, Dale Porter, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2013
Beyond trastuzumab and lapatinib: new options for HER2-positive breast cancer Dimitrios Zardavas, David Cameron, Ian Krop, et al.
Pageof 7